ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1988

Most Fibromyalgia Patients in a Rheumatology Office Practice Accept the Diagnosis of Fibromyalgia

Robert S. Katz1, Jessica L. Polyak2 and Frank Leavitt1, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: diagnosis and fibromyalgia

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: ARHP Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  In the community, many comments are made about fibromyalgia that are not accurate, such as, it is a made-up illness; a ‘garbage’ diagnosis; everything else needs to be excluded to diagnose someone with fibromyalgia; it is an unscientific term; or it is a name used for autoimmune conditions, such as lupus, when the doctor is uncertain. We asked patients with fibromyalgia in a rheumatology office practice what they thought when they were given the diagnosis of fibromyalgia by a rheumatologist.

Methods: 37 patients with clinically diagnosed fibromyalgia were given an in-office questionnaire. The questions included whether fibromyalgia was a diagnosis that made them feel good and that the doctor understood that was the cause of their symptoms; whether they felt that the diagnosis was not accurate; whether they felt that fibromyalgia is a made-up, unscientific term; whether they felt that they really had lupus or some other disorder; and whether they felt that fibromyalgia was not a real diagnosis.

Results: Patients generally accept the diagnosis of fibromyalgia but are concerned that physicians and non-physicians may think that it is “all in their heads”. See table.

Conclusion: The great majority of fibromyalgia patients in a rheumatology office practice felt good that a diagnosis was made to explain their symptoms. Only a minority thought that the diagnosis was either inaccurate or that the term “fibromyalgia” was an unscientific one and not a real diagnosis.

The biggest problem accepting the diagnosis is that many patients think that doctors and others feel that the symptoms are ‘all in your head’.

The word is spreading about fibromyalgia, such that many patients now accept the diagnosis and feel more comfortable that something more serious and progressive is not present. Though fibromyalgia can be challenging to treat, at least in a rheumatology office practice patients do feel more comfortable given that diagnosis.

A few patients will push back, and these can be a source of stress for the patient and for medical practitioners. The ACR 2010 guidelines for the diagnosis, which can be summarized in a one-page sheet that the patient and practitioner fill out, can assist in verifying the diagnosis. Through scientific research, and also advertising FDA approved drugs to patients, the diagnosis of fibromyalgia appears to be generally accepted.

 


Disclosure: R. S. Katz, None; J. L. Polyak, None; F. Leavitt, None.

To cite this abstract in AMA style:

Katz RS, Polyak JL, Leavitt F. Most Fibromyalgia Patients in a Rheumatology Office Practice Accept the Diagnosis of Fibromyalgia [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/most-fibromyalgia-patients-in-a-rheumatology-office-practice-accept-the-diagnosis-of-fibromyalgia/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/most-fibromyalgia-patients-in-a-rheumatology-office-practice-accept-the-diagnosis-of-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology